✦ LIBER ✦

13 Anti-thymocyte globulin (ATG) vs. Basiliximab induction in renal transplant recipients: A long term outcome

✍ Scribed by K Sailaja; P Poorna; VS Reddy; AS Murthy; Uma Maheswar Rao; S Sahariah

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bolus anti-thymocyte globulin induction

✍ M.R.N Nampoory; M Abdulhalim; K.V Johny; F.A Al-Jawad Donia; M.P Nair; T Said; H 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 71 KB

04 Safety and efficacy of basiliximab vs

✍ Ashish Nandwani; AK Hooda; UK Sharma; Ranjith Nair; JS Bishnoi; Arun Kumar 📂 Article 📅 2011 🏛 Medknow Publications 🌐 English ⚖ 137 KB

A pilot study comparing basiliximab and

✍ C. Mariat; A. Afiani; E. Alamartine; D. Thibaudin; J.P. de Filippis; F. Berthoux 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Comparison of outcomes with low-dose ant

✍ Pedro W. Baron; Okechukwu N. Ojogho; Peter Yorgin; Shobha Sahney; Drew Cutler; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

A randomized trial of alemtuzumab vs. an

✍ Alan Farney; Aimee Sundberg; Phillip Moore; Erica Hartmann; Jeff Rogers; William 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Outcomes of living donor renal transplan

✍ Vardhan, Harsh; Prasad, Narayan; Jaiswal, Akhilesh; Yadav, Brijesh; Kumar, Shash 📂 Article 📅 2014 🏛 Medknow Publications 🌐 English ⚖ 507 KB